Proskauer has advised Dimension. Dimension, a venture capital firm focused on the intersection of biotechnology and artificial intelligence, has announced the closing of its latest fund,...
Dimension Closes $800 Million Fund to Expand Science and Compute Investments
Atlas Holdings’ Closing of $6.45 Billion Flagship Fund ACR V
Proskauer advised Atlas Holdings on the deal. Atlas Holdings (“Atlas”) announced the closing of its fifth flagship investment fund, Atlas Capital Resources V LP (“ACR V”)....
Atomico’s Closing of Atomico Growth VI
Proskauer advised Atomico on the transaction. Atomico, a European venture capital firm, announced the closing of fund Atomico Growth VI (“Growth VI”). Growth VI closed with...
Atomico’s Closing of Atomico Venture VI
Proskauer advised Atomico on the transaction. Atomico, a European venture capital firm, announced the closing of fund Atomico Venture VI (“Venture VI”). Venture VI, an early-stage...
Flagship Pioneering’s $3.6 Billion Fundraising
Proskauer represented Flagship Pioneering in the transaction. Flagship Pioneering (“Flagship”), a bioplatform innovation company, raised an additional $3.6 billion of capital to fund the creation and...
Ridgemont Equity Partners IV’s $2.35 Billion Fundraising
Proskauer represented Ridgemont Equity Partners in the transaction. Ridgemont Equity Partners (Ridgemont), a middle market private equity firm, announced the formation of Ridgemont Equity Partners IV...
Flagship Pioneering’s $3.4 Billion Fund VII Closing
Proskauer advised Flagship Pioneering on the transaction. Flagship Pioneering, which conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability, completed the...
Atlas Capital Resources IV’s $3.1 Billion Fundraising
Proskauer advised Atlas Holdings LLC on the deal. Atlas Holdings LLC completed the first and final close of its fourth private equity investment fund, Atlas Capital Resources...